Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biapenem PK/PD and dosing optimization in high-risk febrile neutropenia
ChiCTR1900024945Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Putian University
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of biapenem in febrile neutropenia (FN) (4 arms), sponsored by Affiliated Hospital of Putian University. Primary endpoints: Blood concentration of biapenem, Temperature and 5 more. Started Aug 2019; status: recruiting.
02
Drugs
biapenem
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on ChiCTR1900024945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024945.